SCHEMBL6740663

SCHEMBL6740663

COc1cc(C)cc(NC=O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
GAA P10253 2/20 0.39
MAPT P10636 1/20 0.38
RAPGEF4 Q8WZA2 1/20 0.38
KMT2A Q03164 4/20 0.37
POLB P06746 2/20 0.37
MEN1 O00255 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ACHE P22303 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6560140 0.88 ALDH1A1 (0.50) ALDH1A1GAAKMT2APOLBMEN1
SCHEMBL6740662 0.83 NPSR1 (0.34) ALDH1A1TSHRCYP3A4NPSR1
SCHEMBL424461 0.81 ALDH1A1 (0.44) ALDH1A1GAAMAPTRAPGEF4KMT2A
SCHEMBL23360887 0.79 NQO2 (0.41) ALDH1A1GAAMAPTKMT2APOLB
SCHEMBL21337861 0.79 HTR6 (0.50) ALDH1A1GAAKMT2APOLBMEN1
SCHEMBL13287100 0.75 ALDH1A1 (0.43) ALDH1A1GAAMAPTRAPGEF4KMT2A
SCHEMBL5457585 0.75 HDAC3 (0.47) MAPTNPC1
SCHEMBL6754404 0.74 MAPT (0.53) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL14701817 0.74 ALDH1A1 (0.42) ALDH1A1GAAMAPTRAPGEF4KMT2A
SCHEMBL28555640 0.74 ALDH1A1 (0.42) ALDH1A1GAAMAPTRAPGEF4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689771-B2 TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS, CORNEAL ULCERATION, SOLID TUMOR GROWTH BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-02-10 US disclosed
US-6610731-B2 Antiinflammatory BRISTOL-MYERS SQUIBB COMPANY 2003-08-26 US disclosed
US-6403632-B1 CYCLIC AMIDE DERIVATIVE BRISTOL MYERS SQUIBB PHARMA CO (US) 2002-06-11 US disclosed
US-6376665-B1 ANTIARTHRITIC AGENTS, ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-04-23 US disclosed
EP-1165500-A1 AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES,TNF-ALPHA,AND AGGRECANASE Du Pont Pharmaceuticals Company (US) 2002-01-02 EP disclosed
WO-2000059874-A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 WO disclosed
US-6057336-A ANTIINFLAMMATORY AGENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2000-05-02 US disclosed